verapamil has been researched along with Nervous System Diseases in 10 studies
Verapamil: A calcium channel blocker that is a class IV anti-arrhythmia agent.
verapamil : A racemate comprising equimolar amounts of dexverapamil and (S)-verapamil. An L-type calcium channel blocker of the phenylalkylamine class, it is used (particularly as the hydrochloride salt) in the treatment of hypertension, angina pectoris and cardiac arrhythmia, and as a preventive medication for migraine.
2-(3,4-dimethoxyphenyl)-5-{[2-(3,4-dimethoxyphenyl)ethyl](methyl)amino}-2-(propan-2-yl)pentanenitrile : A tertiary amino compound that is 3,4-dimethoxyphenylethylamine in which the hydrogens attached to the nitrogen are replaced by a methyl group and a 4-cyano-4-(3,4-dimethoxyphenyl)-5-methylhexyl group.
Nervous System Diseases: Diseases of the central and peripheral nervous system. This includes disorders of the brain, spinal cord, cranial nerves, peripheral nerves, nerve roots, autonomic nervous system, neuromuscular junction, and muscle.
| Excerpt | Relevance | Reference |
|---|---|---|
| "The nifedipine response was reproduced by isradipine and by verapamil with IC50 values of 9 and 100 nM, respectively." | 1.28 | Various Ca2+ entry blockers prevent glutamate-induced neurotoxicity. ( Memo, M; Pizzi, M; Ribola, M; Spano, P; Valerio, A, 1991) |
| " The mean nontoxic dose was 320 mg, whereas the mean toxic ingestion was 3." | 1.28 | Calcium channel blocker toxicity. ( Myers, A; Ramoska, EA; Spiller, HA, 1990) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (30.00) | 18.7374 |
| 1990's | 4 (40.00) | 18.2507 |
| 2000's | 2 (20.00) | 29.6817 |
| 2010's | 1 (10.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kubo, Y | 1 |
| Balayssac, D | 1 |
| Cayre, A | 1 |
| Ling, B | 1 |
| Maublant, J | 1 |
| Penault-Llorca, F | 1 |
| Eschalier, A | 1 |
| Coudore, F | 1 |
| Authier, N | 1 |
| Marsh, E | 1 |
| O'Callaghan, P | 1 |
| Smith, P | 1 |
| Fossati, C | 1 |
| Guistiniani, S | 1 |
| van Poeck, KJ | 1 |
| Pizzi, M | 1 |
| Ribola, M | 1 |
| Valerio, A | 1 |
| Memo, M | 1 |
| Spano, P | 1 |
| Wright, BA | 1 |
| Jarrett, DB | 1 |
| Ramoska, EA | 1 |
| Spiller, HA | 1 |
| Myers, A | 1 |
| Price, WA | 2 |
| DiMarzio, LR | 1 |
| Giannini, AJ | 1 |
3 reviews available for verapamil and Nervous System Diseases
| Article | Year |
|---|---|
[Carrier-mediated Transport of Cationic Drugs across the Blood-Tissue Barrier].
Topics: Angiogenesis Inhibitors; Biological Transport; Blood-Brain Barrier; Blood-Retinal Barrier; Cation Tr | 2015 |
The humble electrocardiogram.
Topics: Anticonvulsants; Arrhythmias, Cardiac; Brain Diseases; Electrocardiography; Heart; Humans; Nervous S | 2008 |
[Side-effects of calcium antagonists].
Topics: Calcium Channel Blockers; Cardiovascular Diseases; Drug Hypersensitivity; Drug Interactions; Fendili | 1984 |
7 other studies available for verapamil and Nervous System Diseases
| Article | Year |
|---|---|
Vincristine-induced neuropathy in the rat is not modified by drug-drug interactions with the P-glycoprotein inhibitor verapamil.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 1; Body Weight; Drug Interactions; Ma | 2008 |
[Chronic recurrent headache without neurological abnormalities. Practice guidelines of the Netherlands Society of Neurology].
Topics: Adult; Aged; Chronic Disease; Contraindications; Drug Interactions; Female; Guidelines as Topic; Hea | 1999 |
Various Ca2+ entry blockers prevent glutamate-induced neurotoxicity.
Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl e | 1991 |
Lithium and calcium channel blockers: possible neurotoxicity.
Topics: Bipolar Disorder; Drug Therapy, Combination; Female; Humans; Hypertension; Lithium Carbonate; Middle | 1991 |
Calcium channel blocker toxicity.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Arrhythmias, Cardiac; Child; Child, Preschool; Delaware; | 1990 |
Verapamil-carbamazepine neurotoxicity.
Topics: Bipolar Disorder; Carbamazepine; Drug Synergism; Drug Therapy, Combination; Female; Humans; Middle A | 1988 |
Lithium-verapamil: further considerations.
Topics: Drug Synergism; Humans; Lithium; Nervous System; Nervous System Diseases; Verapamil | 1987 |